| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $144.9M | +12.9% |
| Cost of Revenue | $48.0M | +16.3% |
| Gross Profit | $96.9M | +11.3% |
| R&D Expense | $16.2M | -4.5% |
| SG&A Expense | $33.1M | +14.6% |
| Operating Income | $19.7M | +3.5% |
| Pre-tax Income | $25.7M | +13.3% |
| Income Tax | $2.7M | +123.6% |
| Net Income | $23.1M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $29.6M | -56.5% |
| Short-term Investments | $48.4M | +19.6% |
| Accounts Receivable | $64.1M | +36.5% |
| Inventory | $24.9M | -4.8% |
| Current Assets | $173.7M | -6.4% |
| Total Assets | $242.8M | -4.0% |
| Current Liabilities | $23.4M | +9.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $20.5M | -21.2% |
| Capital Expenditures | $1.3M | -49.4% |
| Investing Cash Flow | -$15.7M | +18.1% |
| Financing Cash Flow | -$43.3M | -1002.9% |
| Free Cash Flow | $19.2M | -18.2% |
| +7.2% |
| EPS (Basic) | $0.40 | +5.3% |
| EPS (Diluted) | $0.40 | +8.1% |
| Total Liabilities |
| $32.8M |
| -1.2% |
| Stockholders' Equity | $210.0M | -4.5% |